NCInnovation’s regional model is designed to help applied university research move closer to commercialization. For many faculty teams—particularly those outside traditional engineering ...

Dr. Sandip Patel discusses findings from a real-world study of biomarker testing in early-stage resected non-small cell lung cancer in the U.S. Although biomarker testing in early-stage non-small cell ...

A new liquid biopsy developed by researchers at the University of Chicago is offering a powerful new window into cancer’s earliest stages by flagging subtle shifts in the gut microbiome. Unlike ...

A new blood test designed to detect early signs of pancreatic cancer is being trialled in the UK. The genomic test analyses blood samples to identify markers of the deadly disease, which often ...

Oncoguard® Liver blood test delivers six times greater sensitivity for very early-stage hepatocellular carcinoma (HCC) versus standard of care. These findings will be presented as late-breaking data ...

Current methods for cancer diagnosis are based on identifying biomarkers—molecules that reveal a particular state or process in the body—produced by the tumor or associated proteins. Not surprisingly, ...